Literature DB >> 17329557

What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines.

J R Hurst1, J A Wedzicha.   

Abstract

Mesh：

Year:  2007        PMID： 17329557      PMCID： PMC2117162          DOI： 10.1136/thx.2007.077883

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  16 in total

Review 1.  Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms.

Authors:  R Debigaré; C H Côté; F Maltais
Journal:  Am J Respir Crit Care Med       Date:  2001-11-01       Impact factor: 21.405

2.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.

Authors:  A Bhowmik; T A Seemungal; R J Sapsford; J A Wedzicha
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

3.  Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease.

Authors:  John R Hurst; Gavin C Donaldson; Wayomi R Perera; Tom M A Wilkinson; John A Bilello; Gerry W Hagan; Rupert S Vessey; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2006-06-23       Impact factor: 21.405

4.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

Authors:  T A Seemungal; G C Donaldson; E A Paul; J C Bestall; D J Jeffries; J A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  1998-05       Impact factor: 21.405

5.  Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.

Authors:  Dennis E Niewoehner; Kathryn Rice; Claudia Cote; Daniel Paulson; J Allen D Cooper; Larry Korducki; Cara Cassino; Steven Kesten
Journal:  Ann Intern Med       Date:  2005-09-06       Impact factor: 25.391

Review 6.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

7.  Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  Peter Calverley; Romain Pauwels; Jørgen Vestbo; Paul Jones; Neil Pride; Amund Gulsvik; Julie Anderson; Claire Maden
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

Review 8.  COPD and osteoporosis.

Authors:  Diane M Biskobing
Journal:  Chest       Date:  2002-02       Impact factor: 9.410

9.  The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.

Authors:  Keith L Hattotuwa; Mariusz J Gizycki; Tareq W Ansari; Peter K Jeffery; Neil C Barnes
Journal:  Am J Respir Crit Care Med       Date:  2002-06-15       Impact factor: 21.405

Review 10.  Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.

Authors:  W Q Gan; S F P Man; A Senthilselvan; D D Sin
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139
View more
  20 in total

1.  [Validation study of MEP questionnaire for simplified detection of exacerbation of chronic obstructive pulmonary disease].

Authors:  Thomas Hering; Axel Krinner; Dietmar Bulenda
Journal:  Pneumologie       Date:  2022-10-18

2.  Evolution of the COPD Assessment Test score during chronic obstructive pulmonary disease exacerbations: determinants and prognostic value.

Authors:  Darwin Feliz-Rodriguez; Santiago Zudaire; Carlos Carpio; Elizabet Martínez; Antonia Gómez-Mendieta; Ana Santiago; Rodolfo Alvarez-Sala; Francisco García-Río
Journal:  Can Respir J       Date:  2013 Sep-Oct       Impact factor: 2.409

3.  Knowledge and attitudes of family physicians coming to COPD continuing medical education.

Authors:  Barbara P Yawn; Peter C Wollan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 4.  Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review.

Authors:  John R Hurst; Jadwiga A Wedzicha
Journal:  BMC Med       Date:  2009-08-07       Impact factor: 8.775

5.  Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot study.

Authors:  John R Hurst; Gavin C Donaldson; Jennifer K Quint; James J P Goldring; Anant R C Patel; Jadwiga A Wedzicha
Journal:  BMC Pulm Med       Date:  2010-10-20       Impact factor: 3.317

6.  Tonsillar cyst: an unusual cause of ventilatory failure.

Authors:  Justin Loke; Matthew Rutter; Ravi Mahadeva
Journal:  JRSM Short Rep       Date:  2010-10-26

7.  Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis.

Authors:  Hai-Lin Zhang; Min Tan; Ai-Min Qiu; Zhang Tao; Chang-Hui Wang
Journal:  BMC Pulm Med       Date:  2017-12-12       Impact factor: 3.317

8.  COPD exacerbation: lost in translation.

Authors:  Demosthenes Makris; Demosthenes Bouros
Journal:  BMC Pulm Med       Date:  2009-01-29       Impact factor: 3.317

9.  The Effectiveness of Traditional Chinese Medicine (TCM) as an Adjunct Treatment on Stable COPD Patients: A Systematic Review and Meta-Analysis.

Authors:  K H Chan; Y Y S Tsoi; M McCall
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-04       Impact factor: 2.629

Review 10.  Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017.

Authors:  Bassam H Mahboub; Mayank Gian Vats; Ashraf Al Zaabi; Mohammed Nizam Iqbal; Tarek Safwat; Fatma Al-Hurish; Marc Miravitlles; Dave Singh; Khaled Asad; Salah Zeineldine; Mohamed S Al-Hajjaj
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.